3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
19
Glioblastoma
18
Breast Neoplasms
18
Squamous Cell Carcinoma of Head and Neck
15
Lung Neoplasms
12
Rectal Neoplasms
11
Oropharyngeal Neoplasms
10
Neoplasms
9
Head and Neck Neoplasms
8
Glioma
8
Astrocytoma
8
Neoplasm Metastasis
7
Sarcoma
6
Esophageal Neoplasms
6
Carcinoma, Squamous Cell
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Gliosarcoma
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma
5
Burkitt Lymphoma
5
Brain Neoplasms
5
Adenocarcinoma of Lung
5
Adenocarcinoma Of Esophagus
5
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
Vincristine
1
Temozolomide
1
Taxes
1
Selenomethionine
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Radiotherapy
×
90 days
×
Clear all
No trials found.